Abstract
The antiapoptotic Bcl-2-family proteins, Bcl-2 and Bcl-xL, are recognized phototargets of photodynamic therapy (PDT) with the mitochondrion-targeting phthalocyanine photosensitizer Pc 4. In the present study, we found that myeloid cell leukemia 1 (Mcl-1), another antiapoptotic member of the Bcl-2 family, was not photodamaged in Pc 4-PDT-treated human carcinoma cells MCF-7c3, MDA-MB468, DU145, and A431, although Mcl-1 turnover was observed after exposure of HeLa or MCF-7c3 cells to a supralethal dose of UVC. In contrast, when human lymphoma U937 and Jurkat cells were treated with Pc 4-PDT, staurosporine (STS) or UVC, Mcl-1 was cleaved to generate a 28-kDa fragment over a 2–4 h period. The cleavage of Mcl-1 was accompanied by the activation of caspases-3, -9, and -8. The broad-specificity caspase inhibitor z-VAD-fmk completely blocked Mcl-1 cleavage induced by PDT, STS or UVC, providing evidence for Mcl-1 as a substrate for caspases. Western blot analysis localized Mcl-1 to mitochondria, ER, and cytosol of both MCF-7c3 and U937 cells, suggesting that Mcl-1 protein, unlike Bcl-2 and Bcl-xL, is not a target for Pc 4-PDT, probably due to its localization to sites removed from those of Pc 4 binding. The 28-kDa cleaved fragment of Mcl-1, which has proapoptotic activity, was produced in PDT-treated lymphoid-derived cells, but not in cells of epithelial origin, suggesting that PDT-induced rapid and extensive apoptosis in lymphoma cells may result in part from the sensitivity of their Mcl-1 to caspase cleavage, removing an important negative control on apoptosis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bae J, Leo CP, Hsu SY and Hsueh AJ . (2000). J. Biol. Chem., 275, 25255–25261.
Bohr VA, Okumoto DS and Hanawalt PC . (1986). Proc. Natl. Acad. Sci. USA, 83, 3830–3833.
Chao DT and Korsmeyer SJ . (1998). Annu. Rev. Immunol., 16, 395–419.
Chao DT, Linette GP, Boise LH, White LS, Thompson CB and Korsmeyer SJ . (1995). J. Exp. Med., 182, 821–828.
Chiu S, Evans HH, Lam M, Nieminen A and Oleinick NL . (2001). Cancer Lett., 165, 51–58.
Clohessy JG, Zhuang J and Brady HJ . (2004). Br. J. Haematol., 125, 655–665.
Cory S and Adams JM . (2002). Nat. Rev. Cancer, 2, 647–656.
Craig RW . (2002). Leukemia, 16, 444–454.
Cuconati A, Mukherjee C, Perez D and White E . (2003). Genes. Dev., 17, 2922–2932.
Dougherty TJ, Gomer CJ, Henderson BW, Jori G, Kessel D, Korbelik M, Moan J and Peng Q . (1998). J. Natl. Cancer Inst., 90, 889–905.
Fujita N and Tsuruo T . (1998). Biochem. Biophys. Res. Commun., 246, 484–488.
Gross A, McDonnell JM and Korsmeyer SJ . (1999). Genes Dev., 13, 1899–1911.
Herrant M, Jacquel A, Marchetti S, Belhacene N, Colosetti P, Luciano F and Auberger P . (2004). Oncogene, 23, 7863–7873.
Herrant M, Luciano F, Loubat A and Auberger P . (2002). Oncogene, 21, 4957–4968.
Hockenbery D, Nunez G, Milliman C, Schreiber RD and Korsmeyer SJ . (1990). Nature, 348, 334–336.
Iglesias-Serret D, Pique M, Gil J, Pons G and Lopez JM . (2003). Arch. Biochem. Biophys., 417, 141–152.
Kessel D and Castelli M . (2001). Photochem. Photobiol., 74, 318–322.
Kessel D and Luo Y . (1999). Cell Death Differ., 6, 28–35.
Kim HR, Luo Y, Li G and Kessel D . (1999). Cancer Res., 59, 3429–3432.
Kitada S, Zapata JM, Andreeff M and Reed JC . (2000). Blood, 96, 393–397.
Kozopas KM, Yang T, Buchan HL, Zhou P and Craig RW . (1993). Proc. Natl. Acad. Sci. USA, 90, 3516–3520.
Krajewski S, Tanaka S, Takayama S, Schibler MJ, Fenton W and Reed JC . (1993). Cancer Res., 53, 4701–4714.
Lam M, Oleinick NL and Nieminen AL . (2001). J. Biol. Chem., 276, 47379–47386.
Leu CM, Chang C and Hu C . (2000). Oncogene, 19, 1665–1675.
Leu JI, Dumont P, Hafey M, Murphy ME and George DL . (2004). Nat. Cell. Biol., 6, 443–450.
Michels J, O'Neill JW, Dallman CL, Mouzakiti A, Habens F, Brimmell M, Zhang KY, Craig RW, Marcusson EG, Johnson PW and Packham G . (2004). Oncogene, 23, 4818–4827.
Nijhawan D, Fang M, Traer E, Zhong Q, Gao W, Du F and Wang X . (2003). Genes. Dev., 17, 1475–1486.
Oleinick NL, Antunez AR, Clay ME, Rihter BD and Kenney ME . (1993). Photochem. Photobiol., 57, 242–247.
Oleinick NL and Evans HH . (1998). Radiat. Res., 150, S146–S156.
Oleinick NL, Morris RL and Belichenko I . (2002). Photochem. Photobiol. Sci., 1, 1–21.
Reed JC . (1995). Hematol. Oncol. Clin. North Am., 9, 451–473.
Reynolds JE, Yang T, Qian L, Jenkinson JD, Zhou P, Eastman A and Craig RW . (1994). Cancer Res., 54, 6348–6352.
Sedlak TW, Oltvai ZN, Yang E, Wang K, Boise LH, Thompson CB and Korsmeyer SJ . (1995). Proc. Natl. Acad. Sci. USA, 92, 7834–7838.
Separovic D, Mann KJ and Oleinick NL . (1998). Photochem. Photobiol., 68, 101–109.
Snowden RT, Sun XM, Dyer MJ and Cohen GM . (2003). Leukemia, 17, 1981–1989.
Trivedi NS, Wang HW, Nieminen AL, Oleinick NL and Izatt JA . (2000). Photochem. Photobiol., 71, 634–639.
Usuda J, Chiu SM, Murphy ES, Lam M, Nieminen AL and Oleinick NL . (2003). J. Biol. Chem., 278, 2021–2029.
Varela N, Munoz-Pinedo C, Ruiz-Ruiz C, Robledo G, Pedroso M and Lopez-Rivas A . (2001). J. Biol. Chem., 276, 17779–17787.
Varnes ME, Chiu SM, Xue LY and Oleinick NL . (1999). Biochem. Biophys. Res. Commun., 255, 673–679.
Vrana JA, Bieszczad CK, Cleaveland ES, Ma Y, Park JP, Mohandas TK and Craig RW . (2002). Cancer Res., 62, 892–900.
Wang NS, Unkila MT, Reineks EZ and Distelhorst CW . (2001). J. Biol. Chem., 276, 44117–44128.
White E . (1996). Genes. Dev., 10, 1–15.
Xue LY, Chiu SM, Fiebig AO, Andrews DW and Oleinick NL . (2003a). Oncogene, 22, 9197–9204.
Xue LY, Chiu SM and Oleinick NL . (2001a). Oncogene, 20, 3420–3427.
Xue LY, Chiu SM and Oleinick NL . (2001b). Exp. Cell. Res., 263, 145–155.
Xue LY, Chiu SM and Oleinick NL . (2003b). Exp. Cell. Res., 283, 135–145.
Yang T, Kozopas KM and Craig RW . (1995). J. Cell. Biol., 128, 1173–1184.
Yin XM, Oltvai ZN and Korsmeyer SJ . (1994). Nature, 369, 321–323.
Zha J, Harada H, Osipov K, Jockel J, Waksman G and Korsmeyer SJ . (1997). J. Biol. Chem., 272, 24101–24104.
Zhou P, Qian L, Kozopas KM and Craig RW . (1997). Blood, 89, 630–643.
Acknowledgements
We thank Dr Helen H Evans for the critical reading of the manuscript. This research was supported by US Public Health Service Grants P01 CA48735, R01 CA83917, and P30 CA43703 from the National Cancer Institute, DHHS.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Xue, Ly., Chiu, Sm. & Oleinick, N. Differential responses of Mcl-1 in photosensitized epithelial vs lymphoid-derived human cancer cells. Oncogene 24, 6987–6992 (2005). https://doi.org/10.1038/sj.onc.1208837
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1208837